Background
Glycogen Synthase Kinase-3 (GSK-3) is a regulatory enzyme which has been implicated in various cancers, Alzheimer's disease, diabetes, bipolar disorder, and depression1. A non-invasive imaging of GSK-3 and understanding its role in disease pathology would be instrumental in disease diagnosis, staging and in therapeutic advancement1.